Gilles Blancho

CD28‐Specific Immunomodulating Antibodies: What Can Be Learned From Experimental Models?

N. Poirier, Bernard Vanhove, Gilles Blancho, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Antibody‐mediated depletion of lymphocyte‐activation gene‐3 (LAG‐3+)‐activated T lymphocytes prevents delayed‐type hypersensitivity in non‐human primates

T. Haudebourg, G. Blancho, F. Triebel, 2011, Clinical and experimental immunology.

T cell response in xenorecognition and xenografts: a review.

S. Brouard, J. Soulillou, G. Blancho, 1999, Human immunology.

Progress and prospects: genetic engineering in xenotransplantation

I. Anegon, G. Blancho, S. Bas-Bernardet, 2008, Gene Therapy.

Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts.

M. de Carli, M. D’Elios, A. Amedei, 1997, Kidney international.

FR104, an Antagonist Anti‐CD28 Monovalent Fab' Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal Allograft

V. Nérrière-Daguin, K. Renaudin, G. Blancho, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle.

G. Blancho, A. Salvetti, D. Favre, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.